BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 37107664)

  • 21. Gene repression via multiplex gRNA strategy in Y. lipolytica.
    Zhang JL; Peng YZ; Liu D; Liu H; Cao YX; Li BZ; Li C; Yuan YJ
    Microb Cell Fact; 2018 Apr; 17(1):62. PubMed ID: 29678175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR Technology for Genome Activation and Repression in Mammalian Cells.
    Du D; Qi LS
    Cold Spring Harb Protoc; 2016 Jan; 2016(1):pdb.prot090175. PubMed ID: 26729910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A CRISPR/dCas9 toolkit for functional analysis of maize genes.
    Gentzel IN; Park CH; Bellizzi M; Xiao G; Gadhave KR; Murphree C; Yang Q; LaMantia J; Redinbaugh MG; Balint-Kurti P; Sit TL; Wang GL
    Plant Methods; 2020; 16():133. PubMed ID: 33024447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus.
    Klinnert S; Chemnitzer A; Rusert P; Metzner KJ
    J Gen Virol; 2022 Jun; 103(6):. PubMed ID: 35671066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible CRISPR-dCas9 Transcriptional Systems for Sensing and Genome Regulation.
    Wu H; Wang F; Jiang JH
    Chembiochem; 2021 Jun; 22(11):1894-1900. PubMed ID: 33433941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional regulation by CRISPR/dCas9 in common wheat.
    Zhou H; Xu L; Li F; Li Y
    Gene; 2022 Jan; 807():145919. PubMed ID: 34454034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational gRNA design based on transcription factor binding data.
    Bergenholm D; Dabirian Y; Ferreira R; Siewers V; David F; Nielsen J
    Synth Biol (Oxf); 2021; 6(1):ysab014. PubMed ID: 34712839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/dCas system as the modulator of gene expression.
    Kazi TA; Biswas SR
    Prog Mol Biol Transl Sci; 2021; 178():99-122. PubMed ID: 33685602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of Inducible CRISPRi and CRISPRa Human Stromal/Stem Cell Lines for Controlled Target Gene Transcription during Lineage Differentiation.
    Chen L; Shi K; Qiu W; Aagaard L; Kassem M
    Stem Cells Int; 2020; 2020():8857344. PubMed ID: 32922451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome and epigenome engineering CRISPR toolkit for
    Williams RM; Senanayake U; Artibani M; Taylor G; Wells D; Ahmed AA; Sauka-Spengler T
    Development; 2018 Feb; 145(4):. PubMed ID: 29386245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants.
    Kiattisewee C; Karanjia AV; Legut M; Daniloski Z; Koplik SE; Nelson J; Kleinstiver BP; Sanjana NE; Carothers JM; Zalatan JG
    ACS Synth Biol; 2022 Dec; 11(12):4103-4112. PubMed ID: 36378874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Leak-Free Inducible CRISPRi/a System for Gene Functional Studies in Plasmodium falciparum.
    Liang X; Boonhok R; Siddiqui FA; Xiao B; Li X; Qin J; Min H; Jiang L; Cui L; Miao J
    Microbiol Spectr; 2022 Jun; 10(3):e0278221. PubMed ID: 35510853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposing CRISPR System for Transcriptional Activation.
    Chen M; Qi LS
    Adv Exp Med Biol; 2017; 983():147-157. PubMed ID: 28639197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model.
    Li R; Xia X; Wang X; Sun X; Dai Z; Huo D; Zheng H; Xiong H; He A; Wu X
    PLoS Biol; 2020 Nov; 18(11):e3000749. PubMed ID: 33253175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Levels of sgRNA as a Major Factor Affecting CRISPRi Knockdown Efficiency in K562 Cells].
    Wang Y; Xie Y; Dong ZC; Jiang XJ; Gong P; Lu J; Wan F
    Mol Biol (Mosk); 2021; 55(1):86-95. PubMed ID: 33566028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing.
    Moradpour M; Abdulah SNA
    Plant Biotechnol J; 2020 Jan; 18(1):32-44. PubMed ID: 31392820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-mediated transcriptional activation with synthetic guide RNA.
    Strezoska Ž; Dickerson SM; Maksimova E; Chou E; Gross MM; Hemphill K; Hardcastle T; Perkett M; Stombaugh J; Miller GW; Anderson EM; Vermeulen A; Smith AVB
    J Biotechnol; 2020 Aug; 319():25-35. PubMed ID: 32470463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
    Wangensteen KJ; Wang YJ; Dou Z; Wang AW; Mosleh-Shirazi E; Horlbeck MA; Gilbert LA; Weissman JS; Berger SL; Kaestner KH
    Hepatology; 2018 Aug; 68(2):663-676. PubMed ID: 29091290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective Blocking of Microbial Transcriptional Initiation by dCas9-NG-Mediated CRISPR Interference.
    Kim B; Kim HJ; Lee SJ
    J Microbiol Biotechnol; 2020 Dec; 30(12):1919-1926. PubMed ID: 32958732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An efficient KRAB domain for CRISPRi applications in human cells.
    Alerasool N; Segal D; Lee H; Taipale M
    Nat Methods; 2020 Nov; 17(11):1093-1096. PubMed ID: 33020655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.